Status:
RECRUITING
Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Cirrhosis
Microbiota
Eligibility:
All Genders
18+ years
Brief Summary
Cirrhosis is a common digestive system disease and represents the final stage of the progression of various chronic liver diseases. During cirrhosis, the intestinal microenvironment is affected due to...
Eligibility Criteria
Inclusion
- ① Patients diagnosed with chronic liver disease or cirrhosis through liver biopsy pathology or clinical laboratory and imaging examinations;
- ② Undergo molecular breath testing within one week of admission.
Exclusion
- Patients who have received antibiotic treatment within one month; ② Patients with severe pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), asthma, or lung malignancies that have not been clinically cured; ③ Patients who are unable to successfully complete the molecular breath test.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06968234
Start Date
March 1 2025
End Date
December 1 2028
Last Update
May 13 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Geriatrics Medical Center
Shanghai, Shanghai Municipality, China, 200000
2
Shanghai Minhang District Central Hospital
Shanghai, Shanghai Municipality, China, 200000
3
Zhongshan Hospital
Shanghai, Shanghai Municipality, China, 200000